Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Cardinal Health™ ChemoPlus™ Full Coverage Gowns, Closed Back, are intended to protect healthcare personnel from exposure to chemotherapy drugs during preparation, handling, and administration.

    The closed back gowns are single use, disposable medical devices provided sterile and non-sterile. The non-sterile, closed back gowns are not intended for use in the operating room.

    The Cardinal Health™ ChemoPlus™ Full Coverage Gowns, Open Back, are intended to protect healthcare personnel from exposure to chemotherapy drugs during preparation, handling, and administration.

    The open back gowns are single use, disposable medical devices provided non-sterile. The open back gown is nonprotective in the back. The open back gowns are not intended for use in the operating room.

    Device Description

    The Cardinal Health™ ChemoPlus™ Full Coverage Closed Back and Open Back Gowns are classified as Class II medical devices under Regulation 21 CFR 878.4040, General & Plastic Surgery Panel, FDA product code FYA, Surgical Gown.

    The ChemoPlus™ Full Coverage Closed Back and Open Back Gowns are made of a laminate with adhesive taped seams. Both closed and open back gowns have a hook and loop closure at the back of the neck and a waist tie feature to secure the gown to the body of the user. The sleeves of the gown have knit cuffs sewn onto the end of the sleeve at the user's wrists to keep the sleeves in place on the wearer. The entire gown including the gown sleeves are made of the same material and utilize the same manufacturing processes.

    AI/ML Overview

    The provided text is a 510(k) Summary for the Cardinal Health™ ChemoPlus™ Full Coverage Gowns, indicating that these are medical devices subject to FDA regulation. The document describes non-clinical performance testing for these gowns.

    It's important to note that this document pertains to physical medical devices (gowns), not an AI/ML powered device or a software as a medical device (SaMD). Therefore, many of the typical acceptance criteria and study components relevant to AI/ML devices (like sample size for test sets, data provenance, number of experts for ground truth, adjudication methods, MRMC studies, standalone performance, training set details, etc.) are not applicable in this context.

    The study described is a series of non-clinical, laboratory-based performance tests conducted on the gowns themselves, adhering to specific industry standards.

    Here's the information from the document relevant to acceptance criteria and the study that proves the device meets them:

    1. A table of acceptance criteria and the reported device performance

    Standards TypePurposeAcceptance CriteriaReported Device Performance
    Liquid Barrier
    AATCC 42Spray ImpactWater ResistancePASS
    AATCC 127Hydrostatic PressureWater ResistancePASS
    ANSI/AAMI PB70:2012 AAMI Level 3Liquid Barrier PerformanceWater Resistance (AAMI Level 3 requirements)PASS
    Chemical Permeation
    ASTM F739-12Permeation of Liquids and Gases through Protective ClothingChemical Permeation Under Continuous ContactPASS (>480 minutes breakthrough for specified chemotherapy drugs with no permeation detected at minimum detectable permeation or 0.1 µg/cm²/min)
    Material Properties
    ASTM D3776/D3776M-17Weight of Woven FabricMaterial WeightPASS
    ASTM D5034 - 9 2017Grab Tensile, Peak Stretch, and Peak Energy – NonwovensTensile StrengthPASS
    ASTM 1683-17 (2018)Standard Test Method for Failure in Sewn Seams of Woven Apparel FabricsSeam StrengthPASS
    ASTM D5587-15 (2019)Standard Test Method for Tearing Strength of Fabrics by the Trapezoid ProcedureTrapezoid TearPASS
    NWSP 160.1Resistance to Linting of Nonwoven Fabrics (Dry)ParticulatePASS
    Flammability
    16 CFR 1610Standard for the Flammability for Clothing TextilesFlammability (Meet Class I)PASS
    Biocompatibility
    ISO 10993-5:2009ISO MEM Elution CytotoxicityCytotoxicity (Non-cytotoxic)PASS
    ISO 10993 10:2010ISO Indirect Primary Skin Irritation TestIrritation (Non-irritating)PASS
    ISO 10993-10:2010Guinea Pig Maximization TestSensitization (Non-sensitizing)PASS
    Sterilization Residuals
    ISO 10993-7:2008 (R) 2012EO Sterilization Residuals (Sterile Catalog Numbers)EO and ECH ResidualsPASS

    Study Proving Acceptance Criteria:
    The study involved "Non-Clinical Performance Testing" of the Cardinal Health™ ChemoPlus™ Full Coverage Gowns (both closed and open back). This testing was conducted according to various recognized industry standards (AAMI, ASTM, AATCC, NWSP, CFR, ISO) to evaluate specific properties of the gowns. The results for all tests, as reported in the document, uniformly indicated "PASS," demonstrating that the proposed devices meet the acceptance criteria for their intended use.

    Specific details for the chemical permeation test (ASTM F739-12) include:

    • Chemotherapy drugs tested: Carmustine, Cisplatin, Cyclophosphamide, Cytarabine Hydrochloride, Dacarbazine, Daunorubicin Hydrochloride, Doxorubicin Hydrochloride, Etoposide, Fluorouracil, Ifosfamide, Methotrexate, Mitomycin C, Mitoxantrone, Paclitaxel, Thiotepa, Vincristine Sulfate.
    • Reported performance: Average standardized breakthrough time for all tested chemotherapy drugs was ">480 minutes."
    • Detection limit: No permeation was detected at either the minimum detectable permeation or 0.1 µg/cm²/min for any of the tested drugs.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This information is not provided in the document. The tests are non-clinical, material performance tests, where "sample size" would refer to the number of gown material specimens tested according to the specific test standard's requirements, rather than patient data. Data provenance (country, retrospective/prospective) is not relevant for this type of materials testing.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This is not applicable. The "ground truth" for material performance criteria is established by the accepted scientific and engineering principles embedded in the referenced ASTM, ISO, AAMI, etc., standards, and the measurement equipment used for testing. It does not involve human expert consensus in the way an AI/ML medical image analysis device would.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This is not applicable as the evaluation is based on objective measurements against defined technical standards, not subjective human interpretations.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. This is not an AI/ML device, nor does it involve human readers or diagnostic tasks.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This is not applicable. This is not an AI/ML algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for these tests is defined by the objective measurement protocols and acceptance limits set forth in the various referenced international and national standards (e.g., AATCC 42, ASTM F739-12, ISO 10993-5:2009). For example, chemical permeation is measured directly using analytical methods, not expert consensus or pathology.

    8. The sample size for the training set

    This is not applicable. This is not an AI/ML device that requires a training set.

    9. How the ground truth for the training set was established

    This is not applicable. This is not an AI/ML device that requires a training set or ground truth for training.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1